Go To Market
Oliver Wyman partners with leading pharmaceutical and biotechnology companies to maximize access and market share through streamlined and highly effective go-to-market strategies. By relentlessly focusing on key influence points within the treatment cycle (diagnosis, treatment, adherence, and compliance), we have helped clients design sales and marketing models that achieve superior growth and profitability. And through targeted segmentation strategies, Oliver Wyman has enabled new levels of effectiveness with tailored approaches, messaging, and offerings for the key demand drivers: patients, physicians, payers, and pharmacists.
Example of Go-to-Market expertise:
- Assessment of the opportunities for pharmaceutical product and service offerings based upon:
- Needs of the key customers, including providers, payers, and employer groups
- Understanding of current expenditures by marketing activity (promotions, sales, etc.), customer category, lifecycle stage, product purpose, and geography
- Identification of the appropriate sales and marketing model to support the franchise needs and maximize market potential
- Recommendations on how to fund the change through reallocation of resources and streamlining operations
- Development of an implementation plan, including resources, key activities, timelines, and investment requirements for piloting new models
Experts
Jim Hall, Mark Mozeson, Terry Stone
